These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 23331715)

  • 1. Golimumab treatment for complicated uveitis.
    Miserocchi E; Modorati G; Pontikaki I; Meroni P; Gerloni V
    Clin Exp Rheumatol; 2013; 31(2):320-1. PubMed ID: 23331715
    [No Abstract]   [Full Text] [Related]  

  • 2. Golimumab in uveitis previously treated with other anti-TNF-alpha drugs: a retrospective study of three cases from a single centre and literature review.
    Calvo-Río V; de la Hera D; Blanco R; Beltrán-Catalán E; Loricera J; Cañal J; Ventosa J; Cifrián JM; Ortiz-Sanjuán F; Rueda-Gotor J; González-Vela MC; González-López M; González-Gay MA
    Clin Exp Rheumatol; 2014; 32(6):864-8. PubMed ID: 25288110
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term treatment with golimumab for severe uveitis.
    Miserocchi E; Modorati G; Pontikaki I; Meroni PL; Gerloni V
    Ocul Immunol Inflamm; 2014 Apr; 22(2):90-5. PubMed ID: 24143896
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effectiveness of infliximab, adalimumab and golimumab for non-infectious refractory uveitis in adults.
    Borrás-Blasco J; Casterá DE; Cortes X; Abad FJ; Rosique-Robles JD; Mallench LG
    Int J Clin Pharmacol Ther; 2015 May; 53(5):377-90. PubMed ID: 25345430
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of seronegative spondyloarthropathy-associated uveitis with golimumab: retrospective case series.
    Faez S; Lobo AM; Sobrin L; Papaliodis GN
    Clin Exp Ophthalmol; 2014; 42(4):392-5. PubMed ID: 24024585
    [No Abstract]   [Full Text] [Related]  

  • 6. Anakinra for resistant Behçet uveitis: why not?
    Emmi G; Silvestri E; Cameli AM; Bacherini D; Vannozzi L; Squatrito D; Emmi L
    Clin Exp Rheumatol; 2013; 31(3 Suppl 77):152-3. PubMed ID: 24064028
    [No Abstract]   [Full Text] [Related]  

  • 7. New Immunosuppressive Therapies in Uveitis Treatment.
    Mérida S; Palacios E; Navea A; Bosch-Morell F
    Int J Mol Sci; 2015 Aug; 16(8):18778-95. PubMed ID: 26270662
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Golimumab as rescue therapy for refractory immune-mediated uveitis: a three-center experience.
    Cordero-Coma M; Calvo-Río V; Adán A; Blanco R; Álvarez-Castro C; Mesquida M; Calleja S; González-Gay MA; Ruíz de Morales JG
    Mediators Inflamm; 2014; 2014():717598. PubMed ID: 24976689
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Infliximab in uveitis treatment.
    Rudometkin N; Mandava N; Deane K; Olson JL
    Arch Ophthalmol; 2006 Aug; 124(8):1211; author reply 1211-2. PubMed ID: 16908832
    [No Abstract]   [Full Text] [Related]  

  • 10. Treating intraocular inflammatory disease in the 21st century.
    Nussenblatt R
    Arch Ophthalmol; 2005 Jul; 123(7):1000-1. PubMed ID: 16009844
    [No Abstract]   [Full Text] [Related]  

  • 11. Anti-TNF-α therapy in patients with refractory uveitis due to Behçet's disease: a 1-year follow-up study of 124 patients.
    Calvo-Río V; Blanco R; Beltrán E; Sánchez-Bursón J; Mesquida M; Adán A; Hernandez MV; Hernandez Garfella M; Valls Pascual E; Martínez-Costa L; Sellas-Fernández A; Cordero Coma M; Díaz-Llopis M; Gallego R; Salom D; García Serrano JL; Ortego N; Herreras JM; Fonollosa A; García-Aparicio AM; Maíz O; Blanco A; Torre I; Fernández-Espartero C; Jovani V; Peiteado-Lopez D; Pato E; Cruz J; Fernández-Cid C; Aurrecoechea E; García M; Caracuel MA; Montilla C; Atanes A; Hernandez FF; Insua S; González-Suárez S; Sánchez-Andrade A; Gamero F; Linares L; Romero-Bueno F; García AJ; Almodovar R; Minguez E; Carrasco Cubero C; Olive A; Vázquez J; Ruiz Moreno O; Jiménez-Zorzo F; Manero J; Muñoz Fernández S; Rueda-Gotor J; González-Gay MA
    Rheumatology (Oxford); 2014 Dec; 53(12):2223-31. PubMed ID: 24996907
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiple Sclerosis-Associated Uveitis.
    Cunningham ET; Pavesio CE; Goldstein DA; Forooghian F; Zierhut M
    Ocul Immunol Inflamm; 2017 Jun; 25(3):299-301. PubMed ID: 28696171
    [No Abstract]   [Full Text] [Related]  

  • 13. Recalcitrant psoriatic uveitis and anti-tumor necrosis factor-α monoclonal antibodies: experience from a psoriasis referral center.
    Fotiadou C; Lazaridou E; Kemanetzi C; Kyrmanidou E; Ioannides D
    Int J Dermatol; 2015 Sep; 54(9):1105-8. PubMed ID: 25557117
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TNF inhibition for ophthalmic indications: current status and outlook.
    Rifkin LM; Birnbaum AD; Goldstein DA
    BioDrugs; 2013 Aug; 27(4):347-57. PubMed ID: 23568177
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-tumor necrosis factor-α therapy in uveitis.
    Cordero-Coma M; Sobrin L
    Surv Ophthalmol; 2015; 60(6):575-89. PubMed ID: 26164735
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biologic agents in experimental autoimmune uveitis.
    Giuliari GP; Sadaka A; Hinkle DM
    Int Ophthalmol; 2014 Feb; 34(1):145-56. PubMed ID: 23494482
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of intravenous secukinumab in noninfectious uveitis requiring steroid-sparing immunosuppressive therapy.
    Letko E; Yeh S; Foster CS; Pleyer U; Brigell M; Grosskreutz CL;
    Ophthalmology; 2015 May; 122(5):939-48. PubMed ID: 25638011
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Infliximab therapy for refractory uveitis: 2-year results of a prospective trial.
    Suhler EB; Smith JR; Giles TR; Lauer AK; Wertheim MS; Kurz DE; Kurz PA; Lim L; Mackensen F; Pickard TD; Rosenbaum JT
    Arch Ophthalmol; 2009 Jun; 127(6):819-22. PubMed ID: 19506209
    [No Abstract]   [Full Text] [Related]  

  • 19. [Guidelines for the management of uveitis in internal medicine].
    Abad S; Sève P; Dhote R; Brézin AP
    Rev Med Interne; 2009 Jun; 30(6):492-500. PubMed ID: 18824279
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treat early and embrace the evidence in favour of anti-TNF-alpha therapy for Behçet's uveitis.
    Lee RW; Dick AD
    Br J Ophthalmol; 2010 Mar; 94(3):269-70. PubMed ID: 20215370
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.